| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-21 | Gemcitabine | cholangiocarcinoma | Resistant | Low | 16762633 | |
| miR-21 | Gemcitabine | ovarian cancer | Sensitive | High | 19237188 | |
| miR-21 | Gemcitabine | pancreatic cancer | Resistant | Low | 19435867 | |
| miR-21 | Gemcitabine | pancreatic cancer | Sensitive | Low | 20388782 | |
| miR-21 | Gemcitabine | pancreatic cancer | Resistant | Low | 20460539 | |
| miR-21 | Gemcitabine | pancreatic cancer | Resistant | Low | 20498843 | |
| miR-21 | Gemcitabine | pancreatic cancer | Resistant | Low | 21376256 | |
| miR-21 | Gemcitabine | adenocarcinoma | Resistant | Low | 22174421 | |
| miR-214 | Gemcitabine | pancreatic cancer | Resistant | High | 23073476 | |
| miR-21 | Gemcitabine | pancreatic cancer | Resistant | Low | 23177026 | |
| miR-21 | Gemcitabine | pancreatic cancer | Resistant | Low | 23293055 | |
| miR-21 | Gemcitabine | pancreatic cancer | Resistant | Low | 23564788 | |
| miR-21 | Gemcitabine | Bladder Carcinoma | Resistant | High | 23946872 | |
| miR-21 | Gemcitabine | pancreatic cancer | Resistant | Low | 24460329 | |
| miR-211 | Gemcitabine | pancreatic cancer | Sensitive | Low | 24940696 | |
| miR-21* | Gemcitabine | pancreatic cancer | Sensitive | High | 25117811 | |
| miR-210 | Gemcitabine | pancreatic cancer | Resistant | High | 25117811 | |
| miR-218 | Gemcitabine | pancreatic cancer | Resistant | High | 25117811 | |
| miR-21 | Gemcitabine | pancreatic ductal adenocarcinoma | Resistant | High | 25184537 | |
| miR-210 | Gemcitabine | pancreatic cancer | Sensitive | High | 25722110 | |
| miR-2113 | Gemcitabine | pancreatic cancer | Resistant | High | 25722110 | |
| miR-21 | Gemcitabine | pancreatic cancer | Resistant | Low | 25846727 |